Cargando…
Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report
INTRODUCTION AND IMPORTANCE: Thrombotic thrombocytopenic purpura (TTP) is a rare disease due to deficiency of ADAMTS13 which can present with anemia and thrombocytopenia. The study highlights the role of PLASMIC score in diagnosis and rituximab in the treatment of this condition. CASE PRESENTATION:...
Autores principales: | Chaurasiya, Prem Shankar, Khatri, Akash, Gurung, Shekhar, Karki, Saurab, Shahi, Sunil, Aryal, Laxmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577965/ https://www.ncbi.nlm.nih.gov/pubmed/36268380 http://dx.doi.org/10.1016/j.amsu.2022.104789 |
Ejemplares similares
-
Prevalence of acute myeloid leukemia and its associated risk factors at a tertiary care center: a retrospective cross-sectional study
por: Chaurasiya, Prem S., et al.
Publicado: (2023) -
Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report
por: Chen, Jian, et al.
Publicado: (2020) -
Refractory Thrombotic Thrombocytopenic Purpura to Therapeutic Plasma Exchange
por: Kiamos, Amy, et al.
Publicado: (2022) -
Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012) -
Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
por: Chen, Haifei, et al.
Publicado: (2017)